|Grant Affiliation:||McElrath: Durability of HIV-Specific Protective Ab Response|
|Strategy:||Protein and peptide vaccines|
|Study Type:||Pre-Clinical Non-NHP|
|Study Start Date:||2018-01-24|
|Study Made Public:||2020-01-29|
Antibody responses to HIV BG505 SOSIP.664 protein formulated with adjuvants in guinea pigs
CAVD 708 is a preclinical guinea pig study assessing antibody responses to the HIV BG505 SOSIP.664 protein formulated with different adjuvants.
Sign in to see full information about this study and to download study data.